Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barend Bouma

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
FEBS Letters|June 17, 2009
Physiological responses to protein aggregates: fibrinolysis, coagulation and inflammation (new roles for old factors)Martijn F B G Gebbink, Barend Bouma, Coen Maas, et al.
The Journal of Biological Chemistry|December 1, 2006
A role for protein misfolding in immunogenicity of biopharmaceuticalsCoen Maas, Suzanne Hermeling, Barend Bouma, et al.
Nature Reviews. Microbiology|April 5, 2005
Amyloids--a functional coat for microorganismsMartijn F B G Gebbink, Dennis Claessen, Barend Bouma, et al.
The Journal of Biological Chemistry|February 13, 2003
Mapping the collagen-binding site in the von Willebrand factor-A3 domainRoland A Romijn, Erik Westein, Barend Bouma, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|October 18, 2008
Identification of fibronectin type I domains as amyloid-binding modules on tissue-type plasminogen activator and three homologsCoen Maas, Bettina Schiks, Remo D Strangi, et al.
Current Biology : CB|November 7, 2002
Tissue-type plasminogen activator is a multiligand cross-beta structure receptorOnno Kranenburg, Barend Bouma, Loes M J Kroon-Batenburg, et al.
Molecular and Cellular Neurosciences|March 2, 2005
Beta-amyloid (Abeta) causes detachment of N1E-115 neuroblastoma cells by acting as a scaffold for cell-associated plasminogen activationOnno Kranenburg, Barend Bouma, Yoony Y J Gent, et al.
The Journal of Biological Chemistry|August 12, 2003
Glycation induces formation of amyloid cross-beta structure in albuminBarend Bouma, Loes M J Kroon-Batenburg, Ya-Ping Wu, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 19, 2007
Activation of human platelets by misfolded proteinsEszter Herczenik, Barend Bouma, Suzanne J A Korporaal, et al.
Drug Discovery Today|January 5, 2025
Revising EU pharmaceutical legislation: will it foster drug repurposing?Mirre Scholte, Sabine E Grimm, Bianca Pauly, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
FEBS Letters|June 17, 2009
Physiological responses to protein aggregates: fibrinolysis, coagulation and inflammation (new roles for old factors)Martijn F B G Gebbink, Barend Bouma, Coen Maas, et al.
The Journal of Biological Chemistry|December 1, 2006
A role for protein misfolding in immunogenicity of biopharmaceuticalsCoen Maas, Suzanne Hermeling, Barend Bouma, et al.
Nature Reviews. Microbiology|April 5, 2005
Amyloids--a functional coat for microorganismsMartijn F B G Gebbink, Dennis Claessen, Barend Bouma, et al.
The Journal of Biological Chemistry|February 13, 2003
Mapping the collagen-binding site in the von Willebrand factor-A3 domainRoland A Romijn, Erik Westein, Barend Bouma, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|October 18, 2008
Identification of fibronectin type I domains as amyloid-binding modules on tissue-type plasminogen activator and three homologsCoen Maas, Bettina Schiks, Remo D Strangi, et al.
Current Biology : CB|November 7, 2002
Tissue-type plasminogen activator is a multiligand cross-beta structure receptorOnno Kranenburg, Barend Bouma, Loes M J Kroon-Batenburg, et al.
Molecular and Cellular Neurosciences|March 2, 2005
Beta-amyloid (Abeta) causes detachment of N1E-115 neuroblastoma cells by acting as a scaffold for cell-associated plasminogen activationOnno Kranenburg, Barend Bouma, Yoony Y J Gent, et al.
The Journal of Biological Chemistry|August 12, 2003
Glycation induces formation of amyloid cross-beta structure in albuminBarend Bouma, Loes M J Kroon-Batenburg, Ya-Ping Wu, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 19, 2007
Activation of human platelets by misfolded proteinsEszter Herczenik, Barend Bouma, Suzanne J A Korporaal, et al.
Drug Discovery Today|January 5, 2025
Revising EU pharmaceutical legislation: will it foster drug repurposing?Mirre Scholte, Sabine E Grimm, Bianca Pauly, et al.
Pageof 2